JAMES KENNETT: Open Payments
NPI 1164565784 · SOMERSET, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 60 payments from 11 companies in 2025. Trend: 2023 $861 · 2024 $1,124 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 39 | $393 |
| Boston Scientific Corporation | 3 | $52 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: LEQVIO, LifeVest, JARDIANCE, Wegovy, Kerendia, ELIQUIS, FARXIGA, BodyGuardian.
Industry payments across KY — which companies pay providers there.
